Provided by Tiger Trade Technology Pte. Ltd.

Metagenomi Technologies, LLC

1.23
+0.03002.50%
Volume:303.20K
Turnover:375.11K
Market Cap:46.47M
PE:-0.49
High:1.26
Open:1.22
Low:1.20
Close:1.20
52wk High:3.95
52wk Low:1.13
Shares:37.78M
Float Shares:25.57M
Volume Ratio:2.43
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4900
EPS(LYR):-2.3634
ROE:-60.61%
ROA:-28.19%
PB:0.41
PE(LYR):-0.52

Loading ...

MGX Resources Reports Higher June Quarter Iron Ore Sales; Shares Rise 3%

MT Newswires Live
·
Jul 20

Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, Phd, as Chief Scientific Officer as it Advances Multi-program Obesity and Metabolic Disease Portfolio

THOMSON REUTERS
·
Jul 15

Chardan Cuts Price Target on Metagenomi to $5 From $7, Keeps Buy Rating

MT Newswires Live
·
Jul 07

Metagenomi is Maintained at Buy by Chardan Capital

Dow Jones
·
Jul 07

AI Backer MGX Fund I Closes $49B in Funding Commitments

Dow Jones
·
Jul 01

Abu Dhabi's MGX Secures $49 Billion for One of the Largest AI Investment Funds Ever Created

Stock News
·
Jul 01

Abu Dhabi's MGX raises US$49 bil for one of the biggest ever AI funds

Dinesh Nair / Bloomberg
·
Jul 01

ASX Penny Stocks To Watch In June 2026

Simply Wall St.
·
Jun 17

Metagenomi Announces Board Changes and Shareholder Meeting Results

TIPRANKS
·
Jun 10

Metagenomi Therapeutics shareholders elect Eckhardt, Bjerkholt as Class II directors

Reuters
·
Jun 10

NVIDIA MGX Ecosystem Expansion: An Efficiency Revolution from 800V to GPU Core Gains Momentum

Deep News
·
May 29

Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference

GlobeNewswire
·
May 28

MGX Group Ceases to Be Substantial Holder in Maronan Metals

TIPRANKS
·
May 27

Analysts Are Bullish on Top Healthcare Stocks: Metagenomi, Inc. (MGX), Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 14

Metagenomi Is Maintained at Overweight by Wells Fargo

Dow Jones
·
May 12

Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX)

TIPRANKS
·
May 12

Metagenomi Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Metagenomi Highlights Q1 Progress on MGX-001 Gene Therapy

TIPRANKS
·
May 12

Metagenomi reports Q1 EPS (61c), consensus (55c)

TIPRANKS
·
May 12

Metagenomi Q1 EPS $(0.61) Misses $(0.55) Estimate, Sales $1.248M Miss $5.925M Estimate

Benzinga Earnings
·
May 12